The opioid-dependance treatment triangle in prisons: medication, continuity, and harm reduction
Watch the second educational webinar of 2022 led by Professor Heino Stöver, joined by Dr Andrej Kastelic as they discuss the treatment of opioid dependance within the prison system and the specific needs from treatment services
Listen to our experts share best practice approaches for transferring patients on daily dose methadone or buprenorphine to long-acting buprenorphine (LAB) and the associated benefits of these treatment formulations in this patient population, with the ability to ask the questions to the experts.
The agenda covered
- Practicalities – pros and cons for ALL treatments (methadone, SL BPN, LAB – including injection/depot and patch [off-label use])
- Differences in perspectives about LAB from incarcerated users in comparison to non-incarcerated
- Harm reduction programmes available
Link to the main paper used in this presentation: Opioid Substitution Treatment in Custodial Settings A Practical Guide
The IOTOD webinar ‘The opioid-dependance treatment triangle in prisons: medication, continuity, and harm reduction’ is supported by grant funding from Camurus. The educational programme is run at arm’s length from the financial supporters and all content is created by the faculty. No funder has had input into the content of the materials or presentations used in the educational programme. PCM Scientific is the medical education company acting as scientific secretariat and webinar organiser.